HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-positive patients with advanced gastric cancer in a large multicentric trial (ToGA study). Subgroup analysis identified adenocarcinomas of the stomach and gastroesophageal (GE) junction with overexpression of HER2 ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Rüschoff, Josef, Dietel, Manfred, Baretton, Gustavo, Arbogast, Susanne, Walch, Axel, Monges, Geneviéve, Chenard, Marie-Pierre, Penault-Llorca, Frédérique, Nagelmeier, Iris, Schlake, Werner, Höfler, H., Kreipe, H. H.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933810/
https://www.ncbi.nlm.nih.gov/pubmed/20665045
http://dx.doi.org/10.1007/s00428-010-0952-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933810/
https://www.ncbi.nlm.nih.gov/pubmed/20665045
http://dx.doi.org/10.1007/s00428-010-0952-2

Ejemplares similares